Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 46 entries
View as:

Pembrolizumab Activity in Patients With Homologous Recombination Competent and Deficient Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03274661 Org: User:
Start: 11/03/17 End: 03/19/22 Due: 03/19/23

Durvalumab and "Booster" Radiation in Metastatic Adenocarcinoma of the Pancreas

Phase: N/A Priority: Normal
NCT ID: NCT03490760 Org: User:
Start: 11/09/18 End: 07/09/20 Due: 07/09/21

South Miami Hospital Fibroid Registry

Phase: N/A Priority: Normal
NCT ID: NCT02362009 Org: User:
Start: 02/28/15 End: 12/31/15 Due: 12/31/16

Trial of Combination Tumor Treating Fields (TTF; Optune), Nivolumab Plus/Minus Ipilimumab for Recurrent Glioblastoma

Phase: N/A Priority: Normal
NCT ID: NCT03430791 Org: User:
Start: 12/05/18 End: 01/27/21 Due: 01/27/22

Prophylactic Radiotherapy of MInimally Symptomatic Spinal Disease

Phase: N/A Priority: Normal
NCT ID: NCT05534321 Org: User:
Start: 08/29/22 End: 09/30/27 Due: 09/30/28

Acute Chest Pain Imaging in the ED With the Combine CCTA and CT Perfusion

Phase: N/A Priority: Normal
NCT ID: NCT02538861 Org: User:
Start: 09/30/15 End: 06/06/19 Due: 06/06/20

Cemiplimab/Peg-Interferon-α in Advanced CSCC

Phase: N/A Priority: Normal
NCT ID: NCT05729139 Org: User:
Start: 07/31/23 End: 07/31/28 Due: 07/31/29

Zanubrutinib With Pemetrexed to Treat Relapsed/Refractory Primary and Secondary Central Nervous System (CNS) Lymphomas

Phase: N/A Priority: Normal
NCT ID: NCT05681195 Org: User:
Start: 04/25/24 End: 02/28/31 Due: 02/28/32

A Study of Lifestyle Intervention in Overweight or Obese Women With Early Stage Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02037542 Org: User:
Start: 09/30/13 End: 05/31/16 Due: 05/31/17

A Web-based Approach to Treating Cardiovascular Disease Risk in Employees With Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT01912209 Org: User:
Start: 08/31/13 End: 02/28/15 Due: 02/28/16

Observational Trial of the Impact of Radiation Dose in Children With Brain and Skull Base Tumors.

Phase: N/A Priority: Normal
NCT ID: NCT03972514 Org: User:
Start: 03/08/19 End: 03/31/30 Due: 03/31/31

Ultrasound to Predict Steal-Syndrome After Arteriovenous-Fistula Creation (UPSAC - Trial)

Phase: N/A Priority: Normal
NCT ID: NCT01468506 Org: User:
Start: 09/30/11 End: 09/30/14 Due: 09/30/15

Assess Use of 18F-Fluciclovine for Patients With Large Brain Metastases Treated With Staged Stereotactic Radiosurgery

Phase: N/A Priority: Normal
NCT ID: NCT04689048 Org: User:
Start: 04/04/22 End: 12/31/26 Due: 12/31/27

Dose-Escalated Spine SbRT for Localized Metastasis to the Spinal Column

Phase: N/A Priority: Normal
NCT ID: NCT04802603 Org: User:
Start: 03/14/21 End: 12/31/26 Due: 12/31/27

PrOton Pulsed reduCed dOse Rate Radiotherapy for Recurrent CNS maligNancies Trial

Phase: N/A Priority: Normal
NCT ID: NCT06397560 Org: User:
Start: 04/30/25 End: 06/30/29 Due: 06/30/30

Repeated TMS at Low Frequencies to Reduce Seizure Occurrence

Phase: N/A Priority: Normal
NCT ID: NCT03154307 Org: User:
Start: 02/19/16 End: 08/23/19 Due: 08/23/20

Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms

Phase: N/A Priority: Normal
NCT ID: NCT01524211 Org: User:
Start: 01/25/12 End: 01/31/32 Due: 01/31/33

Pembrolizumab and Olaparib in Cervical Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT04483544 Org: User:
Start: 12/03/20 End: 12/12/24 Due: 12/12/25

The Impact of Neut During Potassium Chloride Replacement on Pain and Incidence of Phlebitis

Phase: N/A Priority: Normal
NCT ID: NCT02082717 Org: User:
Start: 02/25/14 End: 08/03/18 Due: 08/03/19

Radioprotective Light-weight Caps in the Interventional Cardiology Setting

Phase: N/A Priority: Normal
NCT ID: NCT01620658 Org: User:
Start: 08/31/12 End: 04/30/14 Due: 04/30/15

New Fabric Attenuation Device in Endovascular Interventional Radiology (PREFER)

Phase: N/A Priority: Normal
NCT ID: NCT01450969 Org: User:
Start: 09/30/11 End: 12/31/11 Due: 12/31/12

Stereotactic Body Radiation and Tumor Treating Fields for Locally Advanced Pancreas Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05679674 Org: User:
Start: 09/21/23 End: 06/30/27 Due: 06/30/28

Tucatinib, Trastuzumab, and Capecitabine With SRS for Brain Metastases From HER-2 Positive Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT05553522 Org: User:
Start: 01/29/24 End: 02/28/29 Due: 02/28/30

Study of LUNG Stereotactic Adaptive Ablative Radiotherapy

Phase: N/A Priority: Normal
NCT ID: NCT04917224 Org: User:
Start: 05/02/22 End: 10/01/32 Due: 10/01/33

CD34+ Enriched Transplants From HLA-Compatible Patients With Hematologic Malignancies

Phase: N/A Priority: Normal
NCT ID: NCT04282174 Org: User:
Start: 09/30/22 End: 03/01/30 Due: 03/01/31